Hirsutism.
The endocrine abnormalities associated with the development of androgen-dependent hirsutism have been presented and discussed in the light of the frequent finding of ultrasonographic abnormalities suggestive of polycystic ovary syndrome. A simple protocol of investigation, which should ideally include pelvic ultrasonography, has been presented. The treatment of hirsutism by combined anti-androgen and oestrogen therapy has been detailed and other approaches discussed.
D000311:Adrenal Glands / Q000378:metabolism; D000312:Adrenal Hyperplasia, Congenital / Q000150:complications; D000308:Adrenocortical Hyperfunction / Q000150:complications; D000728:Androgens / Q000378:metabolism; D002927:Cimetidine / Q000627:therapeutic use; D003534:Cyproterone / Q000627:therapeutic use; D005260:Female; D006197:Hair / Q000254:growth & development; D006204:Hair Removal; D006628:Hirsutism / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D011085:Polycystic Ovary Syndrome / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D013148:Spironolactone / Q000627:therapeutic use; D014463:Ultrasonography
D000728:Androgens; D013148:Spironolactone; D002927:Cimetidine; D003534:Cyproterone